Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ganesh Gopalakrishna

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
International Journal of Geriatric Psychiatry|November 6, 2013
Is easier always better?Ganesh Gopalakrishna, John Lauriello
The Primary Care Companion for CNS Disorders|October 21, 2021
Do Not Drink, Do Not Drive: Alcohol Use Disorder in the ElderlyGanesh Gopalakrishna, Nisha Patel
The Primary Care Companion for CNS Disorders|October 23, 2020
Spotting the Zebra: Keeping an Open Mind When Evaluating Cognitive ImpairmentGanesh Gopalakrishna, Kyle Angus Hendrie
Neurodegenerative Disease Management|November 16, 2020
Cannabinoids in the management of frontotemporal dementia: a case seriesGanesh Gopalakrishna, Yazhini Srivathsal, Gurmehr Kaur
International Journal of Psychiatry in Clinical Practice|June 16, 2015
Predictors of length of stay in a psychiatric hospitalGanesh Gopalakrishna, Muaid Ithman, Kari Malwitz
The Journal of Clinical Psychiatry|April 2, 2015
Does indication drive use, or does use drive indication?John Lauriello, Muaid Ithman, Ganesh Gopalakrishna
Clinical Schizophrenia & Related Psychoses|April 14, 2016
Aripiprazole Lauroxil Long-Acting Injectable: The Latest Addition to Second-Generation Long-Acting AgentsArpit Aggarwal, Ganesh Gopalakrishna, John Lauriello
Clinical Schizophrenia & Related Psychoses|May 7, 2013
Long-acting injectable aripiprazole: how might it fit in our tool box?Ganesh Gopalakrishna, Arpit Aggarwal, John Lauriello
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 27, 2026
Increased risk of infusion-related reactions switching between monoclonal antibodies for Alzheimer's disease: A case seriesGanesh Gopalakrishna, Cristina Tandoc, Pallavi Joshi
The Psychiatric Clinics of North America|May 25, 2016
Update on New and Emerging Treatments for SchizophreniaGanesh Gopalakrishna, Muaid H Ithman, John Lauriello
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
International Journal of Geriatric Psychiatry|November 6, 2013
Is easier always better?Ganesh Gopalakrishna, John Lauriello
The Primary Care Companion for CNS Disorders|October 21, 2021
Do Not Drink, Do Not Drive: Alcohol Use Disorder in the ElderlyGanesh Gopalakrishna, Nisha Patel
The Primary Care Companion for CNS Disorders|October 23, 2020
Spotting the Zebra: Keeping an Open Mind When Evaluating Cognitive ImpairmentGanesh Gopalakrishna, Kyle Angus Hendrie
Neurodegenerative Disease Management|November 16, 2020
Cannabinoids in the management of frontotemporal dementia: a case seriesGanesh Gopalakrishna, Yazhini Srivathsal, Gurmehr Kaur
International Journal of Psychiatry in Clinical Practice|June 16, 2015
Predictors of length of stay in a psychiatric hospitalGanesh Gopalakrishna, Muaid Ithman, Kari Malwitz
The Journal of Clinical Psychiatry|April 2, 2015
Does indication drive use, or does use drive indication?John Lauriello, Muaid Ithman, Ganesh Gopalakrishna
Clinical Schizophrenia & Related Psychoses|April 14, 2016
Aripiprazole Lauroxil Long-Acting Injectable: The Latest Addition to Second-Generation Long-Acting AgentsArpit Aggarwal, Ganesh Gopalakrishna, John Lauriello
Clinical Schizophrenia & Related Psychoses|May 7, 2013
Long-acting injectable aripiprazole: how might it fit in our tool box?Ganesh Gopalakrishna, Arpit Aggarwal, John Lauriello
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 27, 2026
Increased risk of infusion-related reactions switching between monoclonal antibodies for Alzheimer's disease: A case seriesGanesh Gopalakrishna, Cristina Tandoc, Pallavi Joshi
The Psychiatric Clinics of North America|May 25, 2016
Update on New and Emerging Treatments for SchizophreniaGanesh Gopalakrishna, Muaid H Ithman, John Lauriello
Pageof 2